Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.

Fonville JM, Fraaij PL, de Mutsert G, Wilks SH, van Beek R, Fouchier RA, Rimmelzwaan GF.

J Infect Dis. 2016 Jan 1;213(1):31-8. doi: 10.1093/infdis/jiv367. Epub 2015 Jul 3.

2.

Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, Osterhaus AD, Fouchier RA, Rimmelzwaan GF.

J Virol. 2014 Feb;88(3):1684-93. doi: 10.1128/JVI.02843-13. Epub 2013 Nov 20.

3.

Recurring influenza B virus infections in seals.

Bodewes R, Morick D, de Mutsert G, Osinga N, Bestebroer T, van der Vliet S, Smits SL, Kuiken T, Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Emerg Infect Dis. 2013 Mar;19(3):511-2. No abstract available.

4.

Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells.

Hillaire ML, Nieuwkoop NJ, Boon AC, de Mutsert G, Vogelzang-van Trierum SE, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2013;8(2):e56164. doi: 10.1371/journal.pone.0056164. Epub 2013 Feb 12.

5.

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2013 Mar;94(Pt 3):583-92. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.

PMID:
23152369
6.

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Clin Vaccine Immunol. 2011 Mar;18(3):469-76. doi: 10.1128/CVI.00396-10. Epub 2011 Jan 5.

7.

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.

Kreijtz JH, Süzer Y, Bodewes R, Schwantes A, van Amerongen G, Verburgh RJ, de Mutsert G, van den Brand J, van Trierum SE, Kuiken T, Fouchier RA, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Gen Virol. 2010 Nov;91(Pt 11):2745-52. doi: 10.1099/vir.0.024885-0. Epub 2010 Aug 18.

PMID:
20719991
8.

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Kreijtz JH, Suezer Y, de Mutsert G, van Amerongen G, Schwantes A, van den Brand JM, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

PLoS One. 2009 Nov 12;4(11):e7790. doi: 10.1371/journal.pone.0007790.

9.

Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

Vaccine. 2009 Oct 23;27(45):6296-9. doi: 10.1016/j.vaccine.2009.03.020.

PMID:
19840663
10.

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Vaccine. 2009 Aug 6;27(36):4983-9. doi: 10.1016/j.vaccine.2009.05.079. Epub 2009 Jun 16.

PMID:
19538996
11.

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2009;4(5):e5538. doi: 10.1371/journal.pone.0005538. Epub 2009 May 14.

12.

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2009 Feb 1;199(3):405-13. doi: 10.1086/595984.

PMID:
19061423
13.

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2008 Jun;82(11):5161-6. doi: 10.1128/JVI.02694-07. Epub 2008 Mar 19.

14.

Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.

Rimmelzwaan GF, Nieuwkoop NJ, de Mutsert G, Boon AC, Kuiken T, Fouchier RA, Osterhaus AD.

Virus Res. 2007 Nov;129(2):175-81. Epub 2007 Aug 22.

PMID:
17714820
15.

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2007 Jun 1;195(11):1598-606. Epub 2007 Apr 17.

PMID:
17471429
16.
17.
18.

Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.

van Baalen CA, Kwa D, Verschuren EJ, Reedijk ML, Boon AC, de Mutsert G, Rimmelzwaan GF, Osterhaus AD, Gruters RA.

J Infect Dis. 2005 Oct 1;192(7):1183-90. Epub 2005 Aug 30.

PMID:
16136460
19.

Preferential HLA usage in the influenza virus-specific CTL response.

Boon AC, De Mutsert G, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Immunol. 2004 Apr 1;172(7):4435-43.

20.

Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.

Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Immunol. 2004 Feb 15;172(4):2453-60.

21.

Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2002 Mar;76(5):2567-72.

22.

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2002 Jan;76(2):582-90.

Supplemental Content

Loading ...
Support Center